{"DataElement":{"publicId":"64694","version":"4","preferredName":"FISH Assessment Amplification Value","preferredDefinition":"the amplification cutpoint value used during analysis with FISH (fluorescence in situ hybridization).","longName":"FISH_ASSESS_AMP_VAL","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2192063","version":"1","preferredName":"FISH Assessment Amplification","preferredDefinition":"information related to FISH amplification assessment.","longName":"FISH_ASSESS_AMP","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2660558","version":"1","preferredName":"Fluorescence in situ Hybridization Physical Examination","preferredDefinition":"A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.:A physical examination is a systemic evaluation of the body and its functions using visual inspection, palpation, percussion, and auscultation, aimed to determine the presence or absence of physical signs of disease or abnormality for individual's health assessment.","longName":"C17563:C20989","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Physical Examination","conceptCode":"C20989","definition":"A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual's health assessment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33E5C497-F487-4C81-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-27","modifiedBy":"ONEDATA","dateModified":"2007-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177624","version":"1","preferredName":"Amplification","preferredDefinition":"Selective replication of DNA sequence within a cell, producing multiple extra copies of that sequence.","longName":"Amplification","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Gene Amplification Technique","conceptCode":"C20589","definition":"This technique refers to selectively replicate DNA sequence of interest to multiple extra copies that meet the need of research or health care activity. Polymerase chain reaction (PCR), can be considered a type of man-made gene amplification process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-5177-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8A09F0E-18A3-1050-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-11-11","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2019300","version":"4","preferredName":"FISH Assessment Amplification Value","preferredDefinition":"the amplification cutpoint value assessment via FISH (fluorescence in situ hybridization).","longName":"FISH_ASSESS_AMP_VAL","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","minLength":"1","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":"2","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184351","version":"1","preferredName":"Value","preferredDefinition":"Value; a numerical quantity measured or assigned or computed.","longName":"Value","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-2187-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2DEFC7F-1C5E-0064-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-30","modifiedBy":"PWEST","dateModified":"2006-06-26","changeDescription":"ISO compliance.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"},{"publicId":"2812245","version":"1","longName":"Phase II Breast Cancer","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811957","version":"1","longName":"Labs","context":"CTEP"},{"publicId":"2811964","version":"1","longName":"Tumor Markers","context":"CTEP"},{"publicId":"2812156","version":"1","longName":"Breast Cancer DataMart","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811932","version":"1","longName":"Pathology Breast","context":"CTEP"},{"publicId":"2811914","version":"1","longName":"Adjuvant Breast","context":"CTEP"},{"publicId":"2811917","version":"1","longName":"Advanced Breast","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811891","version":"1","longName":"Phase II","context":"CTEP"}]}],"AlternateNames":[{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"}],"ReferenceDocuments":[{"name":"CRF Text","type":"Alternate Question Text","description":"FISH Amplification Cutpoint","url":null,"context":"CTEP"},{"name":"Amplification Cutpoint","type":"Preferred Question Text","description":"Amplification Cutpoint","url":null,"context":"CTEP"},{"name":"ECOG CRF 1","type":"Alternate Question Text","description":"Cut Point","url":null,"context":"ECOG-ACRIN"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E2DEF13A-7351-750B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-30","modifiedBy":"ROUILLAS","dateModified":"2014-01-29","changeDescription":"ISO compliance.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}